Actinium Pharmaceuticals reported $2K in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Actinium Pharmaceuticals USD 2K 3K Sep/2025
Amgen USD 50B 2.43B Dec/2025
Bioline Rx USD 6.6M 116K Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Pfizer USD 57.41B 93M Sep/2025